Identity
- Security key
- 24196
- Ticker
- ZNTL
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-04-03
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ZNTL
Detail
Enriched 2026-08-14 20:47
- Market cap
- $307,472,511.06
- Shares outstanding (class)
- 71,671,914
- Shares outstanding (weighted)
- 71,671,914
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 106
- Location
- SAN DIEGO, CA
- Homepage
- https://www.zentalis.com
- Description
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Market cap and share counts drift.